Patient Capital Management’s NVIDIA NVDA Stock Holding History

Patient Capital Management’s Portfolio NVDA Stock Details NVDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$124M	Buy	711,115 +72,301	+11%	+$13.3M	4.53%	6
2025 Q4	$119M	Buy	638,814 +6,130	+1%	+$1.14M	4.6%	7
2025 Q3	$118M	Sell	632,684 -1,489	-0.2%	-$260K	4.73%	6
2025 Q2	$100M	Buy	634,173 +7,221	+1%	+$909K	4.52%	7
2025 Q1	$67.9M	Buy	626,952 +18,389	+3%	+$2.33M	3.49%	13
2024 Q4	$81.7M	Sell	608,563 -165	-0%	-$22.7K	3.77%	8
2024 Q3	$73.9M	Buy	608,728 +2,889	+0.5%	+$341K	3.63%	9
2024 Q2	$74.8M	Sell	605,839 -221	-0%	-$22.3K	3.98%	9
2024 Q1	$54.8M	Buy	+606,060	New	+$43.9M	2.67%	15

Other funds holding NVDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Patient Capital Management's NVDA Position: Q1 2026 in Review

Patient Capital Management increased its NVIDIA (NVDA) stake by 11% in Q1 2026, buying an estimated $13.3M and bringing the position to 711,115 shares worth $124M. The position accounts for 4.53% of the portfolio, ranked #6.

Patient Capital Management first reported a position in NVDA in Q1 2024 and has held it in 9 quarters since. 5,828 funds tracked by Wall St. Rank hold NVDA as of Q1 2026.

Patient Capital Management held 711,115 shares of NVIDIA worth $124M as of Q1 2026.
Patient Capital Management bought 72,301 NVIDIA shares in Q1 2026, an estimated $13.3M.
NVIDIA made up 4.53% of Patient Capital Management's portfolio in Q1 2026, its #6 holding.
Patient Capital Management first reported a position in NVIDIA in Q1 2024 and has held it in 9 quarters since.
5,828 funds tracked by Wall St. Rank held NVIDIA as of Q1 2026.

Based on Patient Capital Management's 13F filing for Q1 2026, filed 14 May 2026.